5 amino 1mq and tirzepatide 5-Amino-1MQ — 50mg | NNMT Inhibitor (NAD+ Axis) 5 amino 1mq and tirzepatide

It causes better glucose control and weight loss in type 2 diabetics

How to Use: Apply post-treatment and leave on for 3045 minutes

Gently remove in the morning

FDA indications According to the Prescribing Information, the wording of the FDA indications for semaglutide injection (Wegovy ) is as follows (the emphasis below in red has been added by us): WEGOVY is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated in combination with a reduced calorie diet and increased physical activity: to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight

XIGDUO XR can cause serious side effects, including: Lactic Acidosis

Overview of Key Process Steps and Control Parameters Potential advantages 1.Dual Cardio- and Renal Protective Effects Semaglutide raw powder significantly reduces the risk of major adverse cardiovascular events in patients with type 2 diabetes and cardiovascular disease, while simultaneously slowing the decline in glomerular filtration rate in patients with chronic kidney disease